SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for PRVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
March 31, 2026 49.61M
December 31, 2025 35.72M
September 30, 2025 46.60M
June 30, 2025 44.32M
March 31, 2025 38.64M
December 31, 2024 40.89M
September 30, 2024 37.74M
June 30, 2024 35.77M
March 31, 2024 38.21M
December 31, 2023 35.85M
September 30, 2023 34.47M
June 30, 2023 32.76M
March 31, 2023 31.24M
Date Value
December 31, 2022 33.33M
September 30, 2022 37.31M
June 30, 2022 37.93M
March 31, 2022 40.77M
December 31, 2021 43.12M
September 30, 2021 38.50M
June 30, 2021 179.84M
March 31, 2021 17.18M
December 31, 2020 18.78M
September 30, 2020 12.50M
June 30, 2020 10.64M
March 31, 2020 13.44M

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Dogecoin Cash, Inc. 0.1237M
Strata Critical Medical, Inc. 15.60M
Talkspace, Inc. 26.67M
Syra Health Corp. 0.7723M
BrightSpring Health Services, Inc. 360.77M